These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36576731)

  • 1. Investigating the Role of DUSP4 in Uveal Melanoma.
    Aughton K; Sabat-Pospiech D; Barlow S; Coupland SE; Kalirai H
    Transl Vis Sci Technol; 2022 Dec; 11(12):13. PubMed ID: 36576731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma.
    Gupta A; Towers C; Willenbrock F; Brant R; Hodgson DR; Sharpe A; Smith P; Cutts A; Schuh A; Asher R; Myers K; Love S; Collins L; Wise A; Middleton MR; Macaulay VM
    Br J Cancer; 2020 Feb; 122(4):506-516. PubMed ID: 31839677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells.
    Kamada H; Yasuhira S; Shibazaki M; Amano H; Maesawa C
    J Invest Dermatol; 2022 Sep; 142(9):2499-2507.e6. PubMed ID: 35189148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
    Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
    Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
    Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
    Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
    Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
    Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.
    Jung HH; Lee SH; Kim JY; Ahn JS; Park YH; Im YH
    Sci Rep; 2016 Sep; 6():33035. PubMed ID: 27604655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-Specificity Phosphatase 4 Promotes Malignant Features in Colorectal Cancer Through Cyclic-AMP Response Element Binding Protein/Protein Kinase CAMP-Activated Catalytic Subunit Beta Activation.
    Pei W; Yin W; Yu T; Zhang X; Zhang Q; Yang X; Shi C; Shen W; Liu G
    Dig Dis Sci; 2024 Aug; 69(8):2856-2874. PubMed ID: 38824257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture.
    Aughton K; Shahidipour H; Djirackor L; Coupland SE; Kalirai H
    Transl Vis Sci Technol; 2020 Jun; 9(7):39. PubMed ID: 32832244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.
    Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK
    Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
    Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
    Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib.
    Porcelli L; Mazzotta A; Garofoli M; Di Fonte R; Guida G; Guida M; Tommasi S; Azzariti A
    Biomed Pharmacother; 2021 Jan; 133():111006. PubMed ID: 33202284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
    Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
    Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox activation of DUSP4 by N-acetylcysteine protects endothelial cells from Cd²⁺-induced apoptosis.
    Barajas-Espinosa A; Basye A; Jesse E; Yan H; Quan D; Chen CA
    Free Radic Biol Med; 2014 Sep; 74():188-199. PubMed ID: 24973647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells.
    Ratsada P; Hijiya N; Hidano S; Tsukamoto Y; Nakada C; Uchida T; Kobayashi T; Moriyama M
    Biochem Biophys Res Commun; 2020 Jul; 528(3):586-593. PubMed ID: 32505357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling.
    Britson JS; Barton F; Balko JM; Black EP
    Biochem Biophys Res Commun; 2009 Dec; 390(3):849-54. PubMed ID: 19836351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Dual-Specificity Protein Phosphatase DUSP4 Reduces Corticosteroid Sensitivity.
    Kobayashi Y; Ito K; Kanda A; Tomoda K; Mercado N; Barnes PJ
    Mol Pharmacol; 2017 May; 91(5):475-481. PubMed ID: 28283554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma.
    Christodoulou E; Rashid M; Pacini C; Droop A; Robertson H; Groningen TV; Teunisse AFAS; Iorio F; Jochemsen AG; Adams DJ; Doorn RV
    Pigment Cell Melanoma Res; 2021 Jan; 34(1):122-131. PubMed ID: 32767816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
    Cagnol S; Rivard N
    Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DUSP4 appears to be a highly localized endogenous inhibitor of epileptic signaling in human neocortex.
    Kirchner A; Bagla S; Dachet F; Loeb JA
    Neurobiol Dis; 2020 Nov; 145():105073. PubMed ID: 32890776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.